Sökning: "5 P2"
Visar resultat 26 - 30 av 53 avhandlingar innehållade orden 5 P2.
26. Immunoregulation and immunotherapy in experimental autoimmune neuritis
Sammanfattning : Experimental autoimmune neuritis (EAN) is a CD4+ T cell mediated autoimmune disease of the peripheral nervous system (PNS). EAN represents an animal model for studying the immunopathogenesis and immunotherapy of Guillain-Barré syndrome (GBS). LÄS MER
27. Synthesis of β-turn and pyridine based peptidomimetics
Sammanfattning : Despite the unfavorable pharmacokinetic properties associated with peptides, they are still of great interest in drug development due to a multitude of interesting biological functions. The development of peptidomimetics strives to maintain or improve the biological activity of a peptide concurrently with removing the unwanted properties. LÄS MER
28. Development and application of new methods for anticancer drug discovery and early evaluation
Sammanfattning : A non-clonogenic assay using the redox dye Alamar Blue and primary human tumor cells (PHTC) from patients and human tumor cell lines (HTCL) was established for rapid screening and evaluation of anticancer drugs. PHTC cultures from chronic lymphocytic leukemia (CLL) and ovarian carcinoma (Ovca) were compared with renal carcinoma (ACHN) and lymphocytic (CCRF-CEM) HTLCs in response to 63 toxic or non-toxic compounds. LÄS MER
29. Immunoregulation of experimental autoimmune neurirtis focuses on cell immunity
Sammanfattning : Experimental autoimmune neuritis (EAN) is a CD4+ T cell mediated autoimmune disease of peripheral nervous system (PNS). EAN can be induced in susceptible animal strains by active immunization with peripheral nerve tissue, the purified peripheral nerve myelin components P2 and PO, or synthetic P2 and PO peptides. LÄS MER
30. Studies on T cells and cytokines in Guillain-Barré syndrome and experimental allergic neuritis
Sammanfattning : Guillain-Barrésyndrome (GBS) is an inflammatory disease of peripheral nerves, characterised by muscle weakness. The nerves are attacked and destroyed by the immune system. The symptoms usually progress over a few weeks and many patients become severely disabled. LÄS MER